Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · N970012/S212

AMS 700 Inflatable Penile Prosthesis (IPP)

Boston Scientific Corp · Decision date Sep 14, 2026

MEDTECHLEDGER EXPLANATIONN970012/S212

What did the FDA decide?

The FDA record for identifier N970012/S212 shows a 30-day notice decision (OK30) dated 2026-09-14, filed by Boston Scientific Corp. The stated change is "use of new kink resistant endcaps and process changes to accommodate those endcaps," categorized as a process change involving a manufacturer, sterilizer, packager or supplier. The product code is JCW, inflatable penile prosthesis, listed under gastroenterology and urology. The record does not describe endcap materials, dimensions, testing data, or which manufacturing steps changed.

The N970012 prefix ties the notice to the existing AMS 700 inflatable penile prosthesis PMA; S212 marks it as a supplement rather than an original approval. A manufacturing notice of this kind concerns how the device is made, and the source statement's stated purpose does not by itself establish safety or clinical effectiveness of the modified device. Because the changed steps are not specified, the scope beyond the kink-resistant endcaps and associated process adjustments remains unknown from this record.

FDA approval order statement

use of new kink resistant endcaps and process changes to accommodate those endcaps
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Gastroenterology, Urology
Decision date
Sep 14, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
N970012/S212
Regulatory pathway
PMA supplement
Product code
JCW
Decision code
OK30
Decision date
Sep 14, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Prosthesis, penis, inflatable.

Product code
JCW
FDA device class
3

Review the original FDA PMA listing for the original approval scope and linked supplements.

FDA decision timeline

  1. N970012/S212 received

    Application receipt date recorded by FDA.

  2. N970012/S212 · FDA decision

    30-Day Notice

Related devices and submissions

Explore the linked device profile

No additional submissions with a verified PMA or product-code relationship are linked here.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Boston Scientific Corp

Headquarters
Not reported
FDA applicant address
100 Boston Scientific Way, Marlboro, MA, 01752

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records